These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20970022)

  • 1. Off-label use of phosphate binders in non-dialysis-dependent CKD.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2010 Nov; 56(5):813-6. PubMed ID: 20970022
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD.
    Kovesdy CP; Kuchmak O; Lu JL; Kalantar-Zadeh K
    Am J Kidney Dis; 2010 Nov; 56(5):842-51. PubMed ID: 20728255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic renal failure causes bone fragility and blood vessel stiffening].
    Keronen S; Martola L; Honkanen E
    Duodecim; 2012; 128(5):465-74. PubMed ID: 22486062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How KDIGO will (or will not) influence the management of hyperphosphatemia.
    Kovesdy CP
    Semin Dial; 2011; 24(1):35-6. PubMed ID: 21338391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 6. The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.
    McAlister L; Pugh P; Greenbaum L; Haffner D; Rees L; Anderson C; Desloovere A; Nelms C; Oosterveld M; Paglialonga F; Polderman N; Qizalbash L; Renken-Terhaerdt J; Tuokkola J; Warady B; Walle JV; Shaw V; Shroff R
    Pediatr Nephrol; 2020 Mar; 35(3):501-518. PubMed ID: 31667620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
    Savica V; Calò LA; Monardo P; Santoro D; Bellinghieri G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2065-8. PubMed ID: 16766546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].
    Douthat WG; Alles A; Marinovich S; Tirado S; Peñalba A; Prudkin S
    Nefrologia; 2003; 23 Suppl 2():95-9. PubMed ID: 12778863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
    Román-García P; Carrillo-López N; Cannata-Andía JB
    J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
    Sánchez González MC; Fernandez Giraldez E; Valdivielso Revilla JM
    Nefrologia; 2008; 28 Suppl 5():39-45. PubMed ID: 18847419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
    Malluche HH; Monier-Faugere MC
    Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phosphate binders].
    Heeb RM
    Med Monatsschr Pharm; 2016 Jun; 39(6):255-60. PubMed ID: 27439258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphate binders : What are the recent evidences ?].
    Bouajila IA; Martin PY; De Seigneux S
    Rev Med Suisse; 2017 Feb; 13(551):468-472. PubMed ID: 28714648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on phosphate binders: The old and the new.
    Cashin J; Battistella M
    CANNT J; 2016; 26(1):17-21; quiz 22-3. PubMed ID: 27215057
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
    Malberti F
    G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate Binders and Targets Over Decades: Do We have it Right Now?
    Marcuccilli M; Chonchol M; Jovanovich A
    Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.
    Locatelli F; Del Vecchio L; Violo L; Pontoriero G
    Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.